세계의 초상자성 입자 시장 보고서(2025년)
Superparamagnetic Particles Global Market Report 2025
상품코드 : 1877916
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,713,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,704,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,695,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

초상자성 입자 시장 규모는 최근 급속히 확대되고 있습니다. 2024년의 12억 3,000만 달러에서 2025년에는 13억 8,000만 달러, CAGR 12.3%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 자기공명 이미징(MRI)의 보급 확대, 나노의료 부문에서의 조사의 진전, 진단 툴의 도입 증가, 암 연구·치료의 진전, 의료 연구에 대한 정부 자금 증가에 기인한다고 생각됩니다.

초상자성 입자 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 21억 7,000만 달러에 달하고, CAGR은 12.0%를 나타낼 전망입니다. 예측 기간의 성장은 표적 약물 전달에 대한 수요 증가, 자기 공명 이미징(MRI)의 이용 확대, 바이오 센서와 진단 툴의 도입 증가, 암에 대한 온열 요법에서의 응용 확대, 연구 기관과 산업 관계자간의 연계 강화에 기인할 것으로 예측됩니다. 예측 기간의 주요 동향으로는 생물의료 이미징 기술의 진보, 약제 전달에 있어서의 고도 응용, 암 진단 기술의 혁신, 나노테크놀로지와의 통합, 자기 공명 이미징 기술의 진보 등을 들 수 있습니다.

맞춤형 의료에 대한 수요가 증가함에 따라 향후 수년간 초상자성 입자 시장의 확대가 이어질 것으로 예측됩니다. 맞춤형 의료는 치료 성과를 향상시키고 부작용을 최소화하기 위해 개인의 유전자 프로파일, 생활 습관 및 환경에 따라 치료법 및 의료 판단을 사용자 정의하는 의료 접근법을 말합니다. 유전자 검사와 정밀 진단 기술의 진보로 의료 전문가가 환자별로 치료법을 조정할 수 있게 됨으로써 맞춤형 의료에 대한 수요가 높아지고 있습니다. 초상자성 입자는 표적 지향형 약물 전달, 분자 이미징, 진단 용도를 지원함으로써 맞춤형 의료에서 중요한 역할을 하고, 궁극적으로 치료 성과의 향상에 공헌합니다. 예를 들어 2024년 2월 미국 비영리단체 ‘맞춤형 의료연합’이 발표한 보고서에 따르면 2023년 미국 식품의약품국(FDA)이 승인한 희소질환용 신규개별화치료는 16건(2022년은 6건)에 이르렀으며, 이 중 7건이 암치료, 3건이 기타 질병용이었습니다. 이와 같이 맞춤형 의료에 대한 수요 증가가 초상자성 입자 시장의 성장을 견인하고 있습니다.

초상자성 입자 시장에서 사업을 전개하는 주요 기업은 체내 구조의 비침습적 시각화를 가능하게 하는 조영제 등의 고도 솔루션의 개발에 주력하고 있습니다. 조영제는 의료 영상에서 특정 조직과 장기의 대비를 향상시키고 진단 정확도를 높이는 물질입니다. 예를 들어, 2023년 12월, 호주 의료 영상 회사인 Immagion Biosystems는 자사 개발의 IBI10103 Phase I 임상 검사 완료와 함께 좋은 결과를 발표했습니다. 본 검사에서는 HER2 양성 원발성 유방암 환자에서의 겨드랑이 림프절 전이의 검출을 목적으로, MRI 보조제로서의 MagSense HER2 이미징제(MSH2IA)의 안전성과 임상적 실현 가능성을 평가했습니다. 이 이미징 에이전트는 캘리포니아 주 샌디에고에 있는 Imagion의 GMP 호환 시설에서 제조된 초상자성 산화철 나노입자를 핵심으로 구성되어 있습니다. 나노입자는 생체적합성 고분자로 코팅되고 단일클론항체 트라스투주맙(허셉틴)과 결합합니다. MSH2IA는 원발 종양 부위 부근에 단회 주사되어 림프계를 이동하면서 HER2 양성 유방암 세포에 선택적으로 결합하여 MRI 이미지의 가시성을 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

Superparamagnetic particles are nanosized magnetic materials, typically composed of iron oxides, that exhibit magnetic properties only when exposed to an external magnetic field. They become magnetized in the presence of the field but lose magnetization once the field is removed. Owing to their small size and strong magnetic responsiveness, they are extensively utilized in biomedical applications such as MRI contrast agents, drug delivery, and magnetic separation.

The primary types of superparamagnetic particles include iron oxide particles, cobalt ferrite particles, nickel ferrite particles, magnetite particles, and others. Iron oxide particles refer to minute particles composed of iron and oxygen that possess magnetic characteristics and are commonly used in biomedical, industrial, and environmental applications. They are available in various sizes, including nanoscale (less than 100 nm), microscale (100 nm to 1 μm), and sub-microscale (1 μm to 10 μm), and are distributed through direct sales, distributors and resellers, online retailers, and third-party platforms. They find applications in biomedical uses, magnetic resonance imaging (MRI), drug delivery systems, biosensors, and magnetic separation, serving end-user industries such as healthcare and life sciences, environmental applications, the food and beverage industry, electronics and consumer goods, and chemicals and pharmaceuticals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The intensifying U.S. tariffs and escalating trade tensions in spring 2025 are expected to have a significant impact on the chemicals sector, which is bearing a disproportionate burden, particularly from tariffs on petrochemicals and intermediates, where affordable domestic substitutes are often unavailable. Producers of specialty chemicals, heavily dependent on Chinese raw materials, are experiencing production disruptions. At the same time, fertilizer manufacturers are seeing profit margins eroded due to tariffs on phosphate imports. In response, companies are ramping up R&D into bio-based alternatives, forming procurement alliances to consolidate buying power, and shifting production to tariff-neutral nations such as Saudi Arabia.

The superparamagnetic particles market research report is one of a series of new reports from The Business Research Company that provides superparamagnetic particles market statistics, including superparamagnetic particles industry global market size, regional shares, competitors with a superparamagnetic particles market share, detailed superparamagnetic particles market segments, market trends and opportunities, and any further data you may need to thrive in the superparamagnetic particles industry. This superparamagnetic particle market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The superparamagnetic particles market size has grown rapidly in recent years. It will grow from $1.23 billion in 2024 to $1.38 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to the increasing use of magnetic resonance imaging, growing research in nanomedicine, rising adoption of diagnostic tools, an increase in cancer research and treatment, and a rise in government funding for medical research.

The superparamagnetic particles market size is expected to see rapid growth in the next few years. It will grow to $2.17 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to increasing demand for targeted drug delivery, rising use of magnetic resonance imaging, growing adoption of biosensors and diagnostic tools, increasing applications in hyperthermia treatment for cancer, and rising collaborations between research organizations and industry players. Major trends in the forecast period include advancements in biomedical imaging, advanced applications in drug delivery, innovation in cancer diagnostics, integration with nanotechnology, and advancements in magnetic resonance imaging.

The growing demand for personalized medicine is expected to drive the expansion of the superparamagnetic particles market in the coming years. Personalized medicine refers to a medical approach that customizes treatment and healthcare decisions based on an individual's genetic profile, lifestyle, and environment to enhance treatment outcomes and minimize side effects. The demand for personalized medicine is increasing due to advancements in genetic testing and precision diagnostics, which enable healthcare professionals to tailor therapies for each patient. Superparamagnetic particles play a key role in personalized medicine by supporting targeted drug delivery, molecular imaging, and diagnostic applications, ultimately contributing to improved therapeutic results. For instance, in February 2024, the Personalized Medicine Coalition, a United States-based non-profit organization, reported that in 2023, the United States Food and Drug Administration approved 16 new personalized treatments for patients with rare diseases, up from six in 2022, including seven cancer therapies and three for other medical conditions. Therefore, the growing demand for personalized medicine is driving the growth of the superparamagnetic particles market.

Key companies operating in the superparamagnetic particles market are focusing on developing advanced solutions, such as imaging agents, to enable non-invasive visualization of internal body structures. Imaging agents are substances that enhance the contrast of specific tissues or organs in medical imaging to improve diagnostic accuracy. For instance, in December 2023, Imagion Biosystems Limited, an Australia-based medical imaging company, announced positive outcomes following the completion of its IBI10103 phase I clinical trial. The study evaluated the safety and clinical feasibility of the MagSense HER2 Imaging Agent (MSH2IA) as an adjunct to MRI for detecting axillary lymph node metastasis in patients with HER2-positive primary breast cancer. This imaging agent is based on a core of superparamagnetic iron oxide nanoparticles produced at Imagion's GMP-compliant facility in San Diego, California. The nanoparticles are coated with biocompatible polymers and conjugated to the monoclonal antibody trastuzumab (Herceptin). MSH2IA is administered as a single injection near the primary tumor site and travels through the lymphatic system, selectively binding to HER2-positive breast cancer cells to improve MRI visualization.

In July 2024, Hologic Inc., a United States-based medical technology company, acquired Endomagnetics Ltd. for 310 million dollars. Through this acquisition, Hologic aims to enhance and diversify its oncology portfolio by incorporating Endomagnetics Ltd's magnetic surgical technologies, thereby strengthening its expertise in advanced cancer diagnostics, minimally invasive treatment solutions, and comprehensive patient care across multiple oncological fields. Endomagnetics Ltd. is a United Kingdom-based manufacturer of products containing superparamagnetic particles.

Major players in the superparamagnetic particles market are Thermo Fisher Scientific Inc., Sigma-Aldrich Co. LLC, Agilent Technologies Inc., Miltenyi Biotec B.V. & Co. KG, GenScript Biotech Corporation, Promega Corporation, JSR Life Sciences LLC, American Elements, Bioclone Inc., Spherotech Inc., Techinstro, nanoComposix Inc., Bang Laboratories, Nanoshel Llc, Cytodiagnostics Inc., Micromod Partikeltechnologie GmbH, Ocean NanoTech LLC, ProSciTech Pty Ltd., Biosensis Pty Ltd., BOC Sciences Ltd., MagQu Co. Ltd.

North America was the largest region in the superparamagnetic particles market in 2024. The regions covered in superparamagnetic particles report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the superparamagnetic particles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The superparamagnetic particles market consists of sales of dynabeads, magnetic separators and racks, dextran-coated magnetic beads, magnetic hyperthermia nanoparticles, and silica-coated magnetic nanoparticles. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Superparamagnetic Particles Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on superparamagnetic particles market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for superparamagnetic particles ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The superparamagnetic particles market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Superparamagnetic Particles Market Characteristics

3. Superparamagnetic Particles Market Trends And Strategies

4. Superparamagnetic Particles Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Superparamagnetic Particles Growth Analysis And Strategic Analysis Framework

6. Superparamagnetic Particles Market Segmentation

7. Superparamagnetic Particles Market Regional And Country Analysis

8. Asia-Pacific Superparamagnetic Particles Market

9. China Superparamagnetic Particles Market

10. India Superparamagnetic Particles Market

11. Japan Superparamagnetic Particles Market

12. Australia Superparamagnetic Particles Market

13. Indonesia Superparamagnetic Particles Market

14. South Korea Superparamagnetic Particles Market

15. Western Europe Superparamagnetic Particles Market

16. UK Superparamagnetic Particles Market

17. Germany Superparamagnetic Particles Market

18. France Superparamagnetic Particles Market

19. Italy Superparamagnetic Particles Market

20. Spain Superparamagnetic Particles Market

21. Eastern Europe Superparamagnetic Particles Market

22. Russia Superparamagnetic Particles Market

23. North America Superparamagnetic Particles Market

24. USA Superparamagnetic Particles Market

25. Canada Superparamagnetic Particles Market

26. South America Superparamagnetic Particles Market

27. Brazil Superparamagnetic Particles Market

28. Middle East Superparamagnetic Particles Market

29. Africa Superparamagnetic Particles Market

30. Superparamagnetic Particles Market Competitive Landscape And Company Profiles

31. Superparamagnetic Particles Market Other Major And Innovative Companies

32. Global Superparamagnetic Particles Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Superparamagnetic Particles Market

34. Recent Developments In The Superparamagnetic Particles Market

35. Superparamagnetic Particles Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기